These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 425611)

  • 21. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.
    Clayman GL; Taylor DL; Liu FJ; Lavedan P; Savage HE; Schantz SP
    Laryngoscope; 1993 Mar; 103(3):299-307. PubMed ID: 7680086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype.
    Swanson SJ; Lin BF; Mullenix MC; Mortensen RF
    J Immunol; 1991 Mar; 146(5):1596-601. PubMed ID: 1704398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genomics of soluble proteins with collagenous domains: C1q, MBL, SP-A, SP-D, conglutinin, and CL-43.
    Kölble K; Reid KB
    Behring Inst Mitt; 1993 Dec; (93):81-6. PubMed ID: 8172588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-directed immobilisation of antibody fragments for detection of C-reactive protein.
    Vikholm-Lundin I; Albers WM
    Biosens Bioelectron; 2006 Jan; 21(7):1141-8. PubMed ID: 15905085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
    Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affinity chromatography of serum proteins using immobilized lectin from Vicia faba.
    Ziska P; Mohr J
    Acta Biol Med Ger; 1977; 36(7-8):1197-8. PubMed ID: 612099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat.
    de Beer FC; Baltz ML; Munn EA; Feinstein A; Taylor J; Bruton C; Clamp JR; Pepys MB
    Immunology; 1982 Jan; 45(1):55-70. PubMed ID: 7056568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding site of C-reactive protein on M-ficolin.
    Tanio M; Wakamatsu K; Kohno T
    Mol Immunol; 2009 Dec; 47(2-3):215-21. PubMed ID: 19853918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.
    Volanakis JE; Narkates AJ
    J Immunol; 1981 May; 126(5):1820-5. PubMed ID: 7217669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of C-reactive protein from the dog.
    Caspi D; Baltz ML; Snel F; Gruys E; Niv D; Batt RM; Munn EA; Buttress N; Pepys MB
    Immunology; 1984 Oct; 53(2):307-13. PubMed ID: 6490086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
    J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of C-reactive protein (CRP) by human peripheral blood lymphocytes in vivo.
    Lozański G; Pawłowski T; Błazczak P; Wiktorowicz K; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):335-9. PubMed ID: 1810225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AGAR-GEL PRECIPITIN-INHIBITION TECHNIQUE FOR C-REACTIVE PROTEIN DETERMINATIONS. II. DEGREE OF SENSITIVITY AND REPRODUCIBILITY.
    RAY JG; SHAY DE
    Appl Microbiol; 1965 May; 13(3):301-4. PubMed ID: 14325265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of phosphate groups in the interaction of human C-reactive protein with galactan polysaccharides.
    Soelter J; Uhlenbruck G
    Immunology; 1986 May; 58(1):139-44. PubMed ID: 3086219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precipitin analysis of C-reactive protein by gel diffusion.
    LIBRETTI A; KAPLAN MA; GOLDIN M
    Proc Soc Exp Biol Med; 1955 Nov; 90(2):481-4. PubMed ID: 13273487
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of "serum lectins": tridacnin, eel serum and C-reactive protein.
    Uhlenbruck G; Karduck D
    Naturwissenschaften; 1979 Oct; 66(10):524-5. PubMed ID: 116136
    [No Abstract]   [Full Text] [Related]  

  • 39. AGAR-GEL PRECIPITIN-INHIBITION TECHNIQUE FOR C-REACTIVE PROTEIN DETERMINATIONS. 3. QUANTITATION OF C-REACTIVE PROTEIN IN SERUM SPECIMENS.
    SHAY DE; RAY JG
    Appl Microbiol; 1965 May; 13(3):305-7. PubMed ID: 14325266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new marker for neuraminidase-treated human serum glycoproteins from the haemolymph of Tridacna maxima (Röding).
    Uhlenbruck G; Steinhausen G; Schwick HG
    J Clin Chem Clin Biochem; 1977 Jan; 15(1):21-6. PubMed ID: 402436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.